Exelixis to Present at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026 Life Science Investing
Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome Life Science Investing
Arrowhead Pharmaceuticals Announces Interim Clinical Data on RNAi-based Obesity Candidates Showing Weight Loss in Obese Patients with Diabetes and Improved Measures of Body Composition Life Science Investing
